Former Apple Executives Close $33M Omni Ventures Fund I for Manufacturing AI Startups
Originally reported by citybiz.co
Omni Ventures, a San Jose-based venture firm founded by former Apple manufacturing executives Simon Lancaster and Sabrina Paseman, has closed an oversubscribed $33 million debut fund. The firm will invest in early-stage startups developing enterprise software for digital engineering, manufacturing operations, robotics, supply-chain management, and workforce productivity. Omni plans to participate in rounds of $2 million or less, targeting founding teams with direct industry experience. The fund leverages the partners' network of over 32,000 manufacturing executives and engineers to help portfolio companies refine products and connect with industry partners.
This fund enters a market where industrial software and factory digitization have become a clear venture theme, but one that remains fragmented and execution-intensive. The manufacturing technology sector has seen a surge in AI-focused investments, yet most factory floors still rely on legacy systems and siloed data. Omni's thesis - that decades of trapped manufacturing data can be unlocked by AI - aligns with a broader push to modernize production and strengthen domestic supply chains. The firm's focus on software over hardware reflects a pragmatic recognition that capital-efficient, scalable solutions are better suited to early-stage venture returns than capital-intensive machine plays. The partners' Apple pedigree provides credibility in a sector where domain expertise and operational networks are critical for portfolio company success.
For the additive manufacturing industry specifically, Omni's fund signals continued investor appetite for software that bridges the gap between design, production, and quality assurance - areas where AM adoption still lags due to workflow fragmentation. The practical test will be whether Omni can identify startups that solve real factory-floor integration problems rather than adding another layer of dashboard software. The firm's network-driven approach and focus on experienced founding teams are sensible given the complexity of industrial sales cycles. Success will depend on disciplined portfolio construction and patient capital, not the partners' former employer brand.
Topics